Developer docs
API playgroundTry for free, no card

Search company profiles

eMurmur

Full company profile

uuid000bgrz

Namestring
eMurmur
Legal namestring
CSD Labs International Inc. and CSD Labs GmbH, d.b.a. eMurmur
Websiteurl
emurmur.com
Company typeenum
Private
Founded yearint
2014
Descriptiontext

eMurmur is a privately-held digital health company that develops AI-powered auscultation software for the automated detection, classification, and documentation of heart murmurs and lung sounds. Founded in Graz, Austria in 2014 by Andreas Schriefl (CEO) and Andreas Reinisch (CTO) and now headquartered in Ottawa, Canada, the company offers a hardware-agnostic platform that works with multiple FDA-cleared digital stethoscopes (Littmann, Riester, Thinklabs, Mintti Health, Muse Diagnostics, Lapsi Health). Its core product, eMurmur Heart AI, applies proprietary machine learning and signal processing to identify S1/S2 heart sounds, detect the presence or absence of abnormal murmurs, and generate hemodynamic insights from heart sound components, with sensitivity and specificity exceeding 85% in clinical validations at Johns Hopkins, CHEO, Duke, and other institutions. The eMurmur Lung AI module adds crackle and wheeze detection, and an eConsult feature plus Live Streaming enable specialist collaboration and remote auscultation over telehealth platforms.

The company monetizes through annual subscription licenses to its web and mobile applications and through API/platform access licensed to telehealth providers and digital stethoscope vendors. The AI software layer is FDA-cleared (three 510(k) clearances) and CE-marked (MDR Class IIa), and the company holds ISO 13485:2016 certification, HIPAA and GDPR compliance, and a proprietary labeled database of thousands of heart recordings paired with gold-standard echocardiogram diagnoses. eMurmur distributes via a direct B2B sales motion with onboarding and SOP support, a free 30-day trial, OEM integrations (3M Littmann, Riester, Lapsi Health), and channel partnerships (MobilDrTech in the US), serving healthcare providers in primary care, urgent care, telehealth, pediatrics, community pharmacy, and medical education.

Short descriptiontext

eMurmur is a privately-held digital health company that develops FDA-cleared, hardware-agnostic AI software for the automated detection and classification of heart murmurs and lung sounds recorded via digital stethoscopes, serving healthcare providers, telehealth platforms, stethoscope vendors, and medical educators.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersOttawa, Canada
HQ citystring
Ottawa
HQ countrystring
Canada
HQ regionstring
North America
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
cardiac auscultation software, AI heart murmur detection, digital stethoscope platform, telehealth auscultation AI, lung sound analysis
Industry1 code
PRIMARYHLACANAG
SaMD – Imaging & Signal Analysis (AI/ML)
Healthcare & Life Sciences/Digital Health & Health IT/Digital Therapeutics (DTx) & Software as a Medical Device (SaMD)
NAICS code2 codes
  • Electromedical and Electrotherapeutic Apparatus Manufacturing334510
  • Software Publishers5132
SIC code2 codes
  • Electromedical & Electrotherapeutic Apparatus3845
  • Services-Prepackaged Software7372
Product category
Cardiac Auscultation AI Software
Social media profiles3 records
GTM motion3 records

Each record includes

Type, Description, Source

Revenue model2 records
1Software License (Subscription)
TypeSubscription Recurring
Description

eMurmur requires a license to use the software. Pricing depends on specific use case, volume, and requirements. A free 30-day trial is offered before purchase. Available as web application and mobile app.

emurmur.com
2API Access for Third-Party Integrators
TypeLicensing Royalties
Description

Offers API access for telehealth solution providers and platform access for stethoscope vendors, enabling integration of eMurmur's AI capabilities into third-party systems.

emurmur.com
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Technology or R&D, Personnel, Marketing or Sales, Operations, Others
Pricing details1 tier
1Enterprise/Tailored pricing for large healthcare organizations
ModelSubscriptionBilling cadenceAnnual
Notes

Volume-based pricing; tailored to organization size and use case. Includes onboarding, training, SOPs, and technical support.

emurmur.com
GTM typeB2B
B2B
Offering typeSoftware
Software
Brand1 of 4 records shown
1eMurmur Heart AI
Description

AI-powered heart murmur detection software that automatically identifies primary heart sounds (S1 and S2) and detects the presence or absence of abnormal heart murmurs

emurmur.com
+3 more records
Core offering1 text field

eMurmur develops and sells AI-powered digital auscultation software that analyzes heart and lung sounds recorded with compatible digital stethoscopes. The platform automatically identifies primary heart sounds (S1/S2), detects the presence or absence of abnormal heart murmurs, and analyzes lung crackles and wheezes, delivering FDA-cleared and CE-marked diagnostic-grade outputs to healthcare providers, telehealth platforms, and stethoscope vendors. The software is hardware-agnostic, supporting multiple stethoscope brands (3M Littmann, Riester, Thinklabs, Mintti Health, Muse Diagnostics, Lapsi Health), and is available via web portal, mobile app, and partner API for integration into third-party systems.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 7 values shown
  • 88% accuracy for pathologic murmur detection (Johns Hopkins study with 3180 recordings)
+6 more records
Product overview1 text field

eMurmur offers a unified platform-plus-modules architecture centered on AI-powered digital auscultation. The core eMurmur Platform provides hardware-agnostic software that works with multiple digital stethoscope models (Littmann, Riester, Thinklabs, Mintti Health, Muse Diagnostics) via mobile app and web portal. The eMurmur Heart AI suite delivers FDA-cleared and CE-marked automated detection of heart murmurs and hemodynamic analysis, while the eMurmur Lung AI module adds crackle and wheeze detection. Supporting modules include eConsult for specialist referrals, Live Streaming for telehealth, and the Littmann Learning/University apps for education. An open API enables stethoscope vendors and telehealth providers to integrate eMurmur's AI layer into their products.

Product and service7 records
1eMurmur Platform
CategoryCore Digital Auscultation Platform
Description

Hardware-agnostic, AI-powered digital auscultation software platform that enables listening, recording, streaming, and analyzing heart, lung, and bowel sounds. Supports in-person, remote, and asynchronous examination workflows via mobile app and web portal. Used by healthcare providers, telehealth platforms, and stethoscope vendors to elevate auscultation accuracy.

2eMurmur Heart AI
CategoryAI Diagnostic Software Module
Description

FDA-cleared and CE-marked AI suite that automatically identifies primary heart sounds (S1/S2), detects the presence or absence of abnormal heart murmurs with expert-level accuracy (>85% in clinical studies), and delivers hemodynamic insights by calculating the energy of specific heart sound components. Now available as an open, hardware-agnostic platform across multiple stethoscope models.

3eMurmur Lung AI
CategoryAI Diagnostic Software Module
Description

AI-powered lung sound analysis for automated detection of crackles and wheezes, providing comprehensive pulmonary assessment as part of the Heart and Lung AI suite.

4eMurmur API / Partner Integration
CategoryAPI and OEM Integration Product
Description

Open API and software integration options for telehealth solution providers and stethoscope vendors, enabling partners to embed eMurmur's Heart AI and Lung AI capabilities into their hardware or software solutions without requiring additional FDA clearance.

5Littmann Learning App
CategoryMedical Education App
Description

Educational app provided by eMurmur for 3M Littmann Stethoscopes, offering students, educators, and clinicians access to real patient heart sounds, lung sounds, and guided learning modules. Trusted by over 100,000 trainees globally.

6Littmann University App
CategoryMedical Education App
Description

Instructor-focused educational app supporting remote classroom capabilities with live streaming of a large library of patient sounds, as well as group testing with immediate results.

7eMurmur Heartpedia
CategoryPatient and Family Education App
Description

Mobile app designed to help patients, parents, and medical professionals understand heart defects through anatomically-correct 3D models and corresponding heart and murmur sound recordings. Available on iOS and Android.

Scale indicator6 records

Each record includes

Type, Value, Description, Source

Partnership8 partners
Strategic tierCoreTypeTechnology or IntegrationAnnounced on2025-11-11
Description

Integration of eMurmur's AI algorithms into Lapsi Health's Keikku 2.0, an FDA-cleared digital stethoscope, to enhance cardiac diagnostic accuracy and improve clinical diagnostics and efficiency across various healthcare settings. The integration combines eMurmur's cardiac AI algorithms with Keikku 2.0's hardware to improve cardiac auscultation and documentation.

Strategic tierCoreTypeTechnology or IntegrationAnnounced on2021-11-26
Description

Collaboration to create a new standard in heart and lung auscultation. Riester's ri-sonic digital stethoscope provides crisp, clear sound quality, coupled with eMurmur's platform for digital auscultation enabling remote auscultation and diagnosis with state-of-the-art quality sound. Riester is a German company with over 60 years of experience producing high-quality stethoscopes and global reach in over 150 countries.

3MobilDrTech, Inc.
Strategic tierCoreTypeChannel Partner/ Reseller/ DistributorAnnounced on2021-11-18
Description

US distribution partner for eMurmur's digital stethoscope platform. MobilDrTech sells to medical providers, telemedicine equipment and service providers, hospitals, health systems, and third-party payers. Founded in 2009, MobilDrTech represents leading manufacturers of telemedicine equipment and developers of telehealth-specific software.

emurmur.com
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2020-12-18
Description

Partnership to launch educational apps - Littmann Learning App and Littmann University App. eMurmur provides the technology powering these apps which offer real patient heart sounds, lung sounds, and guided learning modules. Trusted by 100,000+ trainees. 3M Littmann is a global leader in auscultation technology.

Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2019-08-01
Description

Partnership with wearable technology company for patient-centered simulation, announced August 2019.

Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2016-06-01
Description

eMurmur graduated from CDL's highly competitive seed-stage program for science-based companies after participating in the 9-month CDL-West health stream in 2018.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Multiple clinical validation studies conducted at Johns Hopkins including home-based remote auscultation study (2021), telemedicine study presented at 2019 Architecture of High-Value Health Care Conference, and validation study published in Pediatric Cardiology (2018) demonstrating 88% accuracy.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Dr. Andrew Redington, Chief of Pediatric Cardiology, serves as medical advisor. Original developer of Heartpedia app for congenital heart defect education before eMurmur took over the app.

Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Thinklabs makes the Thinklabs One digital stethoscope, one of eMurmur's supported hardware partners. It is a peer in the digital auscultation ecosystem, though it competes more at the hardware layer while eMurmur provides the AI software layer.

TypeEmerging player
Description

Butterfly Network provides AI-enabled handheld ultrasound (Butterfly iQ) with FDA-cleared diagnostic AI. It is comparable as an emerging AI medical imaging/diagnostics company targeting point-of-care use, though it focuses on ultrasound rather than auscultation.

TypeDirect peer
Description

Eko Health is the leading AI-powered digital stethoscope company, offering FDA-cleared cardiac and pulmonary analysis directly embedded in its CORE stethoscope. It competes head-to-head with eMurmur in AI auscultation, although eMurmur differentiates by being hardware-agnostic and platform-licensed.

TypeEmerging player
Description

Sonavi Labs develops an AI-enabled digital stethoscope (Feelix) with FDA clearance for respiratory and cardiac analysis. It is an emerging competitor to eMurmur in the AI auscultation space, focused on detecting pneumonia and other respiratory conditions.

TypeBroad incumbent
Description

Philips offers telehealth, remote patient monitoring, and cardiac diagnostic solutions at scale. As a broad incumbent in connected cardiac care, it represents both a potential partner and a competitor to eMurmur's remote auscultation capabilities.

TypeEmerging player
Description

M3DICINE builds the Stethee, an AI-enabled stethoscope for cardiac and pulmonary analysis. It is comparable to eMurmur in providing AI auscultation insights, but ships its own bundled hardware rather than licensing software to third-party stethoscope vendors.

TypeDirect peer
Description

StethoMe is a Poland-based digital health company that builds AI algorithms for heart and lung sound analysis, focused on home and pediatric use. It overlaps directly with eMurmur's lung AI and pediatric auscultation capabilities.

TypeEmerging player
Description

iHealth Labs makes connected consumer and clinical health devices including digital stethoscopes. It is comparable as a connected health device manufacturer that could partner with or compete against eMurmur's auscultation AI software layer.

TypeDirect peer
Description

TytoCare offers a remote examination platform with a connected stethoscope enabling telehealth auscultation. It competes with eMurmur in the remote auscultation segment of telehealth, though TytoCare sells bundled hardware while eMurmur is software-only.

TypeBroad incumbent
Description

3M Littmann (now Solventum) is the dominant incumbent in stethoscopes and a key partner via the Littmann Learning App. It is comparable as the largest hardware player whose stethoscopes eMurmur's AI integrates with, and as a potential competitor if it elects to develop in-house auscultation AI.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers5 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
Yes

Docs URL, Description

Integration10 records

Each record includes

Title, Type, Description, Source

AI capability5 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature7 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles2 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance6 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds2 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors2 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

eMurmur

Cardiac Auscultation AI Softwareemurmur.com

eMurmur is a privately-held digital health company that develops FDA-cleared, hardware-agnostic AI software for the automated detection and classification of heart murmurs and lung sounds recorded via digital stethoscopes, serving healthcare providers, telehealth platforms, stethoscope vendors, and medical educators.

What eMurmur does

eMurmur is a privately-held digital health company that develops AI-powered auscultation software for the automated detection, classification, and documentation of heart murmurs and lung sounds. Founded in Graz, Austria in 2014 by Andreas Schriefl (CEO) and Andreas Reinisch (CTO) and now headquartered in Ottawa, Canada, the company offers a hardware-agnostic platform that works with multiple FDA-cleared digital stethoscopes (Littmann, Riester, Thinklabs, Mintti Health, Muse Diagnostics, Lapsi Health). Its core product, eMurmur Heart AI, applies proprietary machine learning and signal processing to identify S1/S2 heart sounds, detect the presence or absence of abnormal murmurs, and generate hemodynamic insights from heart sound components, with sensitivity and specificity exceeding 85% in clinical validations at Johns Hopkins, CHEO, Duke, and other institutions. The eMurmur Lung AI module adds crackle and wheeze detection, and an eConsult feature plus Live Streaming enable specialist collaboration and remote auscultation over telehealth platforms.

The company monetizes through annual subscription licenses to its web and mobile applications and through API/platform access licensed to telehealth providers and digital stethoscope vendors. The AI software layer is FDA-cleared (three 510(k) clearances) and CE-marked (MDR Class IIa), and the company holds ISO 13485:2016 certification, HIPAA and GDPR compliance, and a proprietary labeled database of thousands of heart recordings paired with gold-standard echocardiogram diagnoses. eMurmur distributes via a direct B2B sales motion with onboarding and SOP support, a free 30-day trial, OEM integrations (3M Littmann, Riester, Lapsi Health), and channel partnerships (MobilDrTech in the US), serving healthcare providers in primary care, urgent care, telehealth, pediatrics, community pharmacy, and medical education.

eMurmur firmographics

Firmographics
Name
eMurmur
Legal name
CSD Labs International Inc. and CSD Labs GmbH, d.b.a. eMurmur
Website
https://emurmur.com
Company type
Private
Founded year
2014
Operating status
Operating
Headcount range
1–10 employees
Short description
eMurmur is a privately-held digital health company that develops FDA-cleared, hardware-agnostic AI software for the automated detection and classification of heart murmurs and lung sounds recorded via digital stethoscopes, serving healthcare providers, telehealth platforms, stethoscope vendors, and medical educators.
Ownership category
akta.pro rank

eMurmur industry classification

Industry
Product category
Cardiac Auscultation AI Software
NAICS
Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Software Publishers (5132)
SIC
Electromedical & Electrotherapeutic Apparatus (3845), Services-Prepackaged Software (7372)
akta.pro industry
PRIMARYHLACANAG
SaMD – Imaging & Signal Analysis (AI/ML)
Healthcare & Life Sciences/Digital Health & Health IT/Digital Therapeutics (DTx) & Software as a Medical Device (SaMD)

Keywords

  • Cardiac auscultation software
  • AI heart murmur detection
  • Digital stethoscope platform
  • Telehealth auscultation AI
  • Lung sound analysis

Where eMurmur is headquartered

Location

Headquarters

HQ city
Ottawa
HQ country
Canada
HQ region
North America

Offices2 records

Markets served

eMurmur business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Technology or R&D, Personnel, Marketing or Sales, Operations, Others

Revenue model

  1. Software License (Subscription): eMurmur requires a license to use the software. Pricing depends on specific use case, volume, and requirements. A free 30-day trial is offered before purchase. Available as web application and mobile app.
  2. API Access for Third-Party Integrators: Offers API access for telehealth solution providers and platform access for stethoscope vendors, enabling integration of eMurmur's AI capabilities into third-party systems.

Pricing tiers

ModelBillingPrice
SubscriptionAnnualEnterprise/Tailored pricing for large healthcare organizations

Go-to-market motion3 records

Distribution channels4 records

Marketing channels6 records

eMurmur product offering

Product offering

Core offering

eMurmur develops and sells AI-powered digital auscultation software that analyzes heart and lung sounds recorded with compatible digital stethoscopes. The platform automatically identifies primary heart sounds (S1/S2), detects the presence or absence of abnormal heart murmurs, and analyzes lung crackles and wheezes, delivering FDA-cleared and CE-marked diagnostic-grade outputs to healthcare providers, telehealth platforms, and stethoscope vendors. The software is hardware-agnostic, supporting multiple stethoscope brands (3M Littmann, Riester, Thinklabs, Mintti Health, Muse Diagnostics, Lapsi Health), and is available via web portal, mobile app, and partner API for integration into third-party systems.

Product overview

eMurmur offers a unified platform-plus-modules architecture centered on AI-powered digital auscultation. The core eMurmur Platform provides hardware-agnostic software that works with multiple digital stethoscope models (Littmann, Riester, Thinklabs, Mintti Health, Muse Diagnostics) via mobile app and web portal. The eMurmur Heart AI suite delivers FDA-cleared and CE-marked automated detection of heart murmurs and hemodynamic analysis, while the eMurmur Lung AI module adds crackle and wheeze detection. Supporting modules include eConsult for specialist referrals, Live Streaming for telehealth, and the Littmann Learning/University apps for education. An open API enables stethoscope vendors and telehealth providers to integrate eMurmur's AI layer into their products.

Differentiator

Problem solved

Functional benefit

Brands

  • eMurmur Heart AI: AI-powered heart murmur detection software that automatically identifies primary heart sounds (S1 and S2) and detects the presence or absence of abnormal heart murmurs
  • eMurmur Lung AI
  • Littmann Learning App
  • eMurmur Heartpedia

Products and services

  • eMurmur Platform Hardware-agnostic, AI-powered digital auscultation software platform that enables listening, recording, streaming, and analyzing heart, lung, and bowel sounds. Supports in-person, remote, and asynchronous examination workflows via mobile app and web portal. Used by healthcare providers, telehealth platforms, and stethoscope vendors to elevate auscultation accuracy.
  • eMurmur Heart AI FDA-cleared and CE-marked AI suite that automatically identifies primary heart sounds (S1/S2), detects the presence or absence of abnormal heart murmurs with expert-level accuracy (>85% in clinical studies), and delivers hemodynamic insights by calculating the energy of specific heart sound components. Now available as an open, hardware-agnostic platform across multiple stethoscope models.
  • eMurmur Lung AI AI-powered lung sound analysis for automated detection of crackles and wheezes, providing comprehensive pulmonary assessment as part of the Heart and Lung AI suite.
  • eMurmur API / Partner Integration Open API and software integration options for telehealth solution providers and stethoscope vendors, enabling partners to embed eMurmur's Heart AI and Lung AI capabilities into their hardware or software solutions without requiring additional FDA clearance.
  • Littmann Learning App Educational app provided by eMurmur for 3M Littmann Stethoscopes, offering students, educators, and clinicians access to real patient heart sounds, lung sounds, and guided learning modules. Trusted by over 100,000 trainees globally.
  • Littmann University App Instructor-focused educational app supporting remote classroom capabilities with live streaming of a large library of patient sounds, as well as group testing with immediate results.
  • eMurmur Heartpedia Mobile app designed to help patients, parents, and medical professionals understand heart defects through anatomically-correct 3D models and corresponding heart and murmur sound recordings. Available on iOS and Android.

Quantifiable outcome

  • 88% accuracy for pathologic murmur detection (Johns Hopkins study with 3180 recordings)
  • +6 more outcomes

Companies that use eMurmur

Customer profile

Named customers5 records

Segments4 records

Ideal customer profiles4 records

eMurmur technology and API

Technology

Technology focussed Yes

API detail

Has API
Yes
API docs
API detail

Core technology

AI maturity

App detail

Integration10 records

AI capability5 records

Feature7 records

eMurmur partnerships and signals

Strategic signal

Partnerships

Eight partnerships are on record, tiered core and minor.

  • Lapsi HealthcoreTechnology or Integration · 11 November 2025Integration of eMurmur's AI algorithms into Lapsi Health's Keikku 2.0, an FDA-cleared digital stethoscope, to enhance cardiac diagnostic accuracy and improve clinical diagnostics and efficiency across various healthcare settings. The integration combines eMurmur's cardiac AI algorithms with Keikku 2.0's hardware to improve cardiac auscultation and documentation.
  • Rudolf Riester (Ri-sonic)coreTechnology or Integration · 26 November 2021Collaboration to create a new standard in heart and lung auscultation. Riester's ri-sonic digital stethoscope provides crisp, clear sound quality, coupled with eMurmur's platform for digital auscultation enabling remote auscultation and diagnosis with state-of-the-art quality sound. Riester is a German company with over 60 years of experience producing high-quality stethoscopes and global reach in over 150 countries.
  • MobilDrTech, Inc.coreChannel Partner/ Reseller/ Distributor · 18 November 2021US distribution partner for eMurmur's digital stethoscope platform. MobilDrTech sells to medical providers, telemedicine equipment and service providers, hospitals, health systems, and third-party payers. Founded in 2009, MobilDrTech represents leading manufacturers of telemedicine equipment and developers of telehealth-specific software.
  • 3M Littmann StethoscopescoreStrategic or Co-development Partner · 18 December 2020Partnership to launch educational apps - Littmann Learning App and Littmann University App. eMurmur provides the technology powering these apps which offer real patient heart sounds, lung sounds, and guided learning modules. Trusted by 100,000+ trainees. 3M Littmann is a global leader in auscultation technology.
  • AvkinminorStrategic or Co-development Partner · 1 August 2019Partnership with wearable technology company for patient-centered simulation, announced August 2019.
  • Creative Destruction Labs (CDL)minorStrategic or Co-development Partner · 1 June 2016eMurmur graduated from CDL's highly competitive seed-stage program for science-based companies after participating in the 9-month CDL-West health stream in 2018.
  • Johns Hopkins UniversitycoreStrategic or Co-development PartnerMultiple clinical validation studies conducted at Johns Hopkins including home-based remote auscultation study (2021), telemedicine study presented at 2019 Architecture of High-Value Health Care Conference, and validation study published in Pediatric Cardiology (2018) demonstrating 88% accuracy.
  • Cincinnati Children's HospitalminorStrategic or Co-development PartnerDr. Andrew Redington, Chief of Pediatric Cardiology, serves as medical advisor. Original developer of Heartpedia app for congenital heart defect education before eMurmur took over the app.

Scale indicators6 records

Recent moves7 records

Expansion highlights5 records

eMurmur competitors and assessment

Company assessment

Direct peers

  • Thinklabs: Thinklabs makes the Thinklabs One digital stethoscope, one of eMurmur's supported hardware partners. It is a peer in the digital auscultation ecosystem, though it competes more at the hardware layer while eMurmur provides the AI software layer.
  • Eko Health: Eko Health is the leading AI-powered digital stethoscope company, offering FDA-cleared cardiac and pulmonary analysis directly embedded in its CORE stethoscope. It competes head-to-head with eMurmur in AI auscultation, although eMurmur differentiates by being hardware-agnostic and platform-licensed.
  • StethoMe: StethoMe is a Poland-based digital health company that builds AI algorithms for heart and lung sound analysis, focused on home and pediatric use. It overlaps directly with eMurmur's lung AI and pediatric auscultation capabilities.
  • TytoCare: TytoCare offers a remote examination platform with a connected stethoscope enabling telehealth auscultation. It competes with eMurmur in the remote auscultation segment of telehealth, though TytoCare sells bundled hardware while eMurmur is software-only.

Emerging players

  • Butterfly Network: Butterfly Network provides AI-enabled handheld ultrasound (Butterfly iQ) with FDA-cleared diagnostic AI. It is comparable as an emerging AI medical imaging/diagnostics company targeting point-of-care use, though it focuses on ultrasound rather than auscultation.
  • Sonavi Labs: Sonavi Labs develops an AI-enabled digital stethoscope (Feelix) with FDA clearance for respiratory and cardiac analysis. It is an emerging competitor to eMurmur in the AI auscultation space, focused on detecting pneumonia and other respiratory conditions.
  • M3DICINE (Stethee): M3DICINE builds the Stethee, an AI-enabled stethoscope for cardiac and pulmonary analysis. It is comparable to eMurmur in providing AI auscultation insights, but ships its own bundled hardware rather than licensing software to third-party stethoscope vendors.
  • iHealth Labs: iHealth Labs makes connected consumer and clinical health devices including digital stethoscopes. It is comparable as a connected health device manufacturer that could partner with or compete against eMurmur's auscultation AI software layer.

Broad incumbents

  • Philips Healthcare: Philips offers telehealth, remote patient monitoring, and cardiac diagnostic solutions at scale. As a broad incumbent in connected cardiac care, it represents both a potential partner and a competitor to eMurmur's remote auscultation capabilities.
  • 3M Littmann / Solventum: 3M Littmann (now Solventum) is the dominant incumbent in stethoscopes and a key partner via the Littmann Learning App. It is comparable as the largest hardware player whose stethoscopes eMurmur's AI integrates with, and as a potential competitor if it elects to develop in-house auscultation AI.

Market position

Strengths5 records

Competitive moat6 records

Key risks5 records

Key highlights7 records

Customer concentration

eMurmur social profiles

Digital presence

eMurmur compliance and trust

Trust signal

Compliance6 records

eMurmur financial estimates

Financial estimate

Revenue estimate

Valuation estimate

eMurmur leadership team

Management profile

Number of profiles

Profiles2 records

eMurmur funding detail

Funding detail

Funding overview

Funding rounds2 records

Investors2 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

eMurmur M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about eMurmur

What does eMurmur do?

eMurmur develops and sells AI-powered digital auscultation software that analyzes heart and lung sounds recorded with compatible digital stethoscopes. The platform automatically identifies primary heart sounds (S1/S2), detects the presence or absence of abnormal heart murmurs, and analyzes lung crackles and wheezes, delivering FDA-cleared and CE-marked diagnostic-grade outputs to healthcare providers, telehealth platforms, and stethoscope vendors. The software is hardware-agnostic, supporting multiple stethoscope brands (3M Littmann, Riester, Thinklabs, Mintti Health, Muse Diagnostics, Lapsi Health), and is available via web portal, mobile app, and partner API for integration into third-party systems.

Is eMurmur a public or private company?

eMurmur is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was eMurmur founded?

eMurmur was founded in 2014. It employs 1 to 10 people.

Where is eMurmur based?

eMurmur is headquartered in Ottawa, Canada, in the North America region.

How does eMurmur make money?

Two revenue lines are on record. Software License (Subscription) is the primary driver. The others are API Access for Third-Party Integrators.

Who are eMurmur's main competitors?

Direct peers on record are Thinklabs, Eko Health, StethoMe and TytoCare. Emerging players are Butterfly Network, Sonavi Labs, M3DICINE (Stethee) and iHealth Labs. Broad incumbents are Philips Healthcare and 3M Littmann / Solventum.

Does eMurmur have an API?

Yes. eMurmur offers API access for telehealth solution providers and stethoscope vendors. The API enables third-party integration of eMurmur's auscultation capabilities including heart sound analysis, murmur detection, and lung AI into partner systems. Available through secure API integration with flexible options ranging from AI analysis of recordings to software interfaces for listening, recording, and streaming with high-fidelity audio. Partners can integrate the AI layer without requiring additional FDA clearance. Developer documentation is at emurmur.com/b2b.

What industry is eMurmur in?

eMurmur's product category is Cardiac Auscultation AI Software. Its primary akta.pro industry code is HLACANAG, SaMD – Imaging & Signal Analysis (AI/ML). Its NAICS code is 334510 and its SIC code is 3845.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Mpo-magFDA Clears AI-Powered Heart Murmur Detection SoftwareeMurmur has received U.S. Food and Drug Administration 510(k) clearance for its Heart AI suite, a set of algorithms that evaluate heart recordings from digital stethoscopes to automatically identify primary heart sounds (S1 and S2) and detect the presence or absence of abnormal heart murmurs. This is eMurmur's third FDA clearance and the first authorization that enables use across any supported stethoscope, making it an open, hardware-agnostic platform. The company positions this as a milestone toward building a broad auscultation AI layer compatible with multiple recording devices and telehealth solutions for various clinical settings.PR NewswireeMurmur's Open Medical AI Receives FDA Clearance, Enabling Murmur Detection Across Digital Stethoscope Models and Third-Party SoftwareeMurmur's Heart AI software has received FDA clearance, enabling it to be used across various digital stethoscope models and third-party systems. The AI provides accurate analysis of heart sounds, detection of murmurs, and hemodynamic insights, facilitating diverse clinical applications. This clearance marks eMurmur's third FDA approval, establishing it as a leader in auscultation AI in the US and EU.MassDeviceFDA clears eMurmur’s next-gen AI heart murmur detection softwareeMurmur has received FDA 510(k) clearance for its next-generation heart murmur detection software, eMurmur Heart AI (2.2), which expands compatibility with additional digital stethoscope models and introduces new features for analyzing heart sound components and their ratios. The medtech company, with offices in Graz, Austria and Ottawa, Ontario, aims to position itself as an AI layer powering digital auscultation devices. The clearance enables the software to be integrated into customers' existing software and hardware without requiring additional FDA clearance.PR NewswireLapsi Health and eMurmur® Unveil AI Analytics Integration for Keikku 2.0Lapsi Health and eMurmur announced a partnership to integrate eMurmur's cardiac AI algorithms into Keikku 2.0, the world's first FDA-cleared smart stethoscope. The integration combines eMurmur's FDA-cleared murmur detection (90% sensitivity and specificity) with Keikku's AI scribe, available via software update. The partnership aims to deliver cardiologist-level auscultation insights across specialties.NewswireLapsi Health and eMurmur® Unveil AI Analytics Integration for Keikku 2.0Lapsi Health and eMurmur announced a partnership to integrate eMurmur's FDA-cleared cardiac murmur detection AI algorithms into Keikku 2.0, the world's first FDA-cleared smart stethoscope with an integrated AI scribe. The combined platform delivers 90% sensitivity and specificity in detecting abnormal heart murmurs alongside AI-driven transcription, enabling physician-level cardiac auscultation with simultaneous patient documentation. The integrated solution will be deployed to Keikku 2.0 users via a software update with no additional hardware required.PR NewswireThinklabs Teams Up with eMurmur® to Provide Remote Auscultation CapabilitiesThinklabs Medical and eMurmur announced a partnership on December 8, 2022, to launch a remote auscultation system combining the Thinklabs One digital stethoscope with eMurmur's cloud-based software platform. The system enables healthcare professionals to screen, diagnose, and consult on heart, lung, and bowel health remotely through telemedicine, home-based screening, or asynchronous specialist consultations. Both companies' CEOs highlighted the system's potential for expanded remote patient monitoring capabilities and improved distance care for patients.PR Newswire3M™ Littmann® Stethoscopes and eMurmur® Partner to Launch New Educational Apps3M™ Littmann® Stethoscopes has partnered with eMurmur® to launch two educational mobile apps for medical training: the Littmann Learning App for students and the Littmann University App for instructors. The apps provide access to real patient heart sound recordings and enable virtual classroom capabilities for remote auscultation training, addressing challenges posed by pandemic-era remote learning. The collaboration combines 3M Littmann's auscultation expertise with eMurmur's AI-powered digital auscultation technology to help clinicians master heart murmur detection.PR NewswireeMurmur receives CE mark certification for its heart murmur detection solutioneMurmur announced that its eMurmur ID heart murmur detection solution has received CE mark certification, making it the only heart murmur detection solution with both FDA clearance and European market clearance. The mobile and cloud-based platform uses advanced machine learning to identify and classify pathologic and innocent heart murmurs with over 85% accuracy. The certification enables the company to market the solution across the European Economic Area following its prior U.S. FDA clearance.